A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

Clinical trial NCT06075810 · RECRUITING

Trial details

NCT number: NCT06075810
Sponsor: MBQ Pharma
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasm Breast Cancer Stage IV

Start date: 2023-11-09
Primary completion: 2025-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.